VIKING GLOBAL INVESTORS LP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for VIKING GLOBAL INVESTORS LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of VIKING GLOBAL INVESTORS LP. VIKING GLOBAL INVESTORS LP is a 10% Owner in FIRST DATA CORP ($FDC) and a 10% Owner in Arbutus Biopharma Corp ($TKMR) and a 10% Owner in Adaptive Biotechnologies Corp ($ADPT) and a 10% Owner in Wayfair Inc. ($W) and a 10% Owner in Axovant Sciences Ltd. ($AXON) and a 10% Owner in 4D Molecular Therapeutics Inc. ($FDMT) and a 10% Owner in Editas Medicine, Inc. ($EDIT) and a 10% Owner in Myovant Sciences Ltd. ($MYOV) and a 10% Owner in Zentalis Pharmaceuticals, Inc. ($ZNTL) and a 10% Owner in Inhibrx, Inc. ($INBX) and a 10% Owner in BridgeBio Pharma, Inc. ($BBIO) and a 10% Owner in Urovant Sciences Ltd. ($UROV).
Address: 55 RAILROAD AVENUE GREENWICH 06830 CT
Companies in which VIKING GLOBAL INVESTORS LP is an Insider
4D Molecular Therapeutics Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of VIKING GLOBAL INVESTORS LP: 10% Owner
Holdings: 2,004,581 shares
Latest Transaction: Dec 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Adaptive Biotechnologies Corp
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of VIKING GLOBAL INVESTORS LP: 10% Owner
Holdings: 29,993,708 shares
Latest Transaction: Dec 16 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Arbutus Biopharma Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of VIKING GLOBAL INVESTORS LP: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 16 2018
$TKMR Market Capitalization: $138.47M
$TKMR Previous Close: $2.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BridgeBio Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of VIKING GLOBAL INVESTORS LP: 10% Owner
Holdings: 11,736,137 shares
Latest Transaction: Jun 28 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Editas Medicine, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of VIKING GLOBAL INVESTORS LP: 10% Owner
Holdings: 266,782 shares
Current Value: $4,951,474
Latest Transaction: Feb 08 2016
$EDIT Market Capitalization: $636.78M
$EDIT Previous Close: $18.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
FIRST DATA CORP
Industry: SERVICES-BUSINESS SERVICES, NEC [7389]
Position of VIKING GLOBAL INVESTORS LP: 10% Owner
Holdings: 5,874,105 shares
Current Value: $91,048,628
Latest Transaction: Apr 15 2016
$FDC Market Capitalization: $13.80B
$FDC Previous Close: $15.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Inhibrx, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of VIKING GLOBAL INVESTORS LP: 10% Owner
Holdings: 1,327,307 shares
Latest Transaction: Aug 28 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Myovant Sciences Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of VIKING GLOBAL INVESTORS LP: 10% Owner
Holdings: 40,765,599 shares
Current Value: $434,968,941
Latest Transaction: Jun 13 2019
$MYOV Market Capitalization: $630.81M
$MYOV Previous Close: $10.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sio Gene Therapies Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of VIKING GLOBAL INVESTORS LP: 10% Owner
Holdings: 105,952,381 shares
Current Value: $1,374,202,382
Latest Transaction: Mar 19 2019
$AXON Market Capitalization: $1.28B
$AXON Previous Close: $12.97
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Urovant Sciences Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of VIKING GLOBAL INVESTORS LP: 10% Owner
Holdings: 22,848,350 shares
Latest Transaction: Jun 19 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Wayfair Inc.
Industry: RETAIL-CATALOG & MAIL-ORDER HOUSES [5961]
Position of VIKING GLOBAL INVESTORS LP: 10% Owner
Holdings: 538,711 shares
Current Value: $22,949,089
Latest Transaction: Nov 24 2014
$W Market Capitalization: $3.64B
$W Previous Close: $42.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Zentalis Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of VIKING GLOBAL INVESTORS LP: 10% Owner
Holdings: 4,443,284 shares
Latest Transaction: Apr 08 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of VIKING GLOBAL INVESTORS LP
Sentiment: All, FDMT, ADPT, TKMR, BBIO, EDIT, FDC, INBX, MYOV, AXON, UROV, W, ZNTL
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17 2020 | FDMT | 4D Molecular Thera ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 833,333 | 0 | 0 | |
| Dec 17 2020 | FDMT | 4D Molecular Thera ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 2,004,581 | 0 | 0 | |
| Dec 17 2020 | FDMT | 4D Molecular Thera ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 23.00 | 1,100,000 | 25,300,000 | 3,937,914 | 2.8 M to 3.9 M (+38.76 %) |
| Dec 17 2020 | FDMT | 4D Molecular Thera ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 833,333 | 0 | 2,837,914 | 2 M to 2.8 M (+41.57 %) |
| Dec 17 2020 | FDMT | 4D Molecular Thera ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 2,004,581 | 0 | 2,004,581 | 0 to 2 M |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Sell | S | 55.65 | 1,000,000 | 55,650,000 | 29,993,708 | 31 M to 30 M (-3.23 %) |
| Nov 13 2020 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Sell | S | 49.52 | 2,500,000 | 123,787,500 | 30,993,708 | 33.5 M to 31 M (-7.46 %) |